GSK Says Regulatory Submission For Co’s Daprodustat Accepted Into Health Canada Review

Diamondback Energy reported quarterly adjusted earnings of $4.74 per share which beat the analyst consensus estimate of $4.66 by 1.72%. The company reported quarterly sales of $2.23 billion which beat the analyst consensus estimate of $2.17 billion by 2.67% and represents a 9.75% increase over sales of $2.03 billion from the same period last year.